Breast Cancer Therapies
Ribociclib
BPT-1206 · Tablet
What is it used for?
Blocks CDK4/6 to slow cancer-cell division. Used with endocrine therapy for specified hormone-receptor-positive, HER2-negative breast cancers, including certain high-risk early-stage and advanced or metastatic settings.
- Dosage form
- Tablet
- Listed strengths
- 200 mg
- Listed pack size
- 63's
- Mechanism
- CDK4/6 inhibitor
Specifications supplied in the Everest product list; formulation, pack configuration, availability and local authorization require confirmation. These medicines are not for self-medication.
Clinical use overview
- Selected HR-positive, HER2-negative early breast cancers
- HR-positive, HER2-negative advanced or metastatic breast cancer
Important information
Educational information about the active ingredient, not a treatment recommendation or a claim that Beptide's presentation is approved. Approved uses differ by country and product. Cancer medicines require specialist assessment; biomarkers, stage, previous treatments and combinations can determine eligibility.
FDA prescribing information
